Ondine Biomedical has partnered with Mela Solutions, whose software is used in 90% of NHS intensive care units, to help hospitals quickly assess the cost-saving impact of its Steriwave antimicrobial treatment. Steriwave uses light to activate a treatment inside the nose that kills bacteria causing infections, which can extend hospital stays and increase costs. The collaboration allows NHS trusts to compare Steriwave's effects against historical data, aiming to demonstrate clinical benefits and cost reductions within weeks. This follows positive trial results showing significant infection reductions, potentially easing NHS bed demand without new construction.
Ondine Biomedical is the subject of this news, providing context for readers interested in health innovations. For readers following the health sector, here is Pluang's market snapshot as of Sep 29, 2026 13:12 WIB: Out of 100 priced US health stocks, 42 rose and 51 fell. Notable movers include TDOC at USD 5.88 with a -3.45% change and a typical hold time of 39 days, TMDX at USD 82.54 with a -3.22% change and 97% sell order activity, and ABEO at USD 5.13 with a -3.02% change and a typical hold time of 23 days.
Grande Portage Resources announced that the official federal permitting timetable for its New Amalga Gold Project in Southeast Alaska has been posted on the Federal Permitting Dashboard under the FAST-41 program. This milestone marks a key step in th...
The PUMP token surged 17% in 24 hours, extending its weekly gains to 38%, driven by Pump.fun's aggressive buyback program which has spent over $466 million to reduce circulating supply by nearly 17%. The platform's seven-day revenue reached $15.16 mi...
XRP's price is currently trading near $1.48, with significant institutional demand shown by $22.65 million net inflows into U.S. spot XRP ETFs on September 25, totaling about $1.79 billion cumulatively. Recent XRPL network upgrades and an upcoming Ev...
Hedera's cryptocurrency HBAR surged over 20% in 24 hours, reaching a high of $0.1306 before settling near $0.118 amid heavy trading. The price rally followed significant enterprise developments, including The Hashgraph Group's IDTrust identity platfo...
Close Brothers Group PLC shares rose nearly 11% after the company reported cost savings of £36 million for the year ending 31 July, surpassing its £25 million target. The group expects savings to exceed £60 million by the end of 2027. Despite a 17% d...
